- Home
- AXGN vs BBNX Comparison
AXGN vs BBNX Comparison
Compare AXGN & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXGN
- BBNX
- Stock Information
- Founded
- AXGN N/A
- BBNX 2015
- Country
- AXGN United States
- BBNX United States
- Employees
- AXGN N/A
- BBNX N/A
- Industry
- AXGN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- BBNX Medical/Dental Instruments
- Sector
- AXGN Health Care
- BBNX Health Care
- Exchange
- AXGN Nasdaq
- BBNX Nasdaq
- Market Cap
- AXGN 1.1B
- BBNX 1.2B
- IPO Year
- AXGN N/A
- BBNX 2025
- Fundamental
- Price
- AXGN $27.08
- BBNX $31.44
- Analyst Decision
- AXGN Strong Buy
- BBNX Strong Buy
- Analyst Count
- AXGN 7
- BBNX 11
- Target Price
- AXGN $27.71
- BBNX $28.09
- AVG Volume (30 Days)
- AXGN 921.9K
- BBNX 723.4K
- Earning Date
- AXGN 10-29-2025
- BBNX 10-28-2025
- Dividend Yield
- AXGN N/A
- BBNX N/A
- EPS Growth
- AXGN N/A
- BBNX N/A
- EPS
- AXGN N/A
- BBNX N/A
- Revenue
- AXGN $214,709,000.00
- BBNX $88,570,000.00
- Revenue This Year
- AXGN $21.57
- BBNX $52.13
- Revenue Next Year
- AXGN $15.79
- BBNX $36.07
- P/E Ratio
- AXGN N/A
- BBNX N/A
- Revenue Growth
- AXGN 18.72
- BBNX 67.01
- 52 Week Low
- AXGN $9.22
- BBNX $8.89
- 52 Week High
- AXGN $27.64
- BBNX $32.11
- Technical
- Relative Strength Index (RSI)
- AXGN 80.52
- BBNX 71.02
- Support Level
- AXGN $23.00
- BBNX $26.13
- Resistance Level
- AXGN $24.92
- BBNX $29.22
- Average True Range (ATR)
- AXGN 1.13
- BBNX 2.00
- MACD
- AXGN 0.12
- BBNX 0.16
- Stochastic Oscillator
- AXGN 86.79
- BBNX 90.36
About AXGN Axogen Inc.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.
About BBNX Beta Bionics Inc. Common Stock
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.